As of May 22
| -0.59 / -1.85%|
The 9 analysts offering 12-month price forecasts for Medicines Co have a median target of 45.00, with a high estimate of 54.00 and a low estimate of 39.00. The median estimate represents a +43.63% increase from the last price of 31.33.
The current consensus among 9 polled investment analysts is to Buy stock in Medicines Co. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.